Navigation Links
Life saving treatment for fire ant allergy under used
Date:3/3/2013

ARLINGTON HEIGHTS, ILL. (March 4, 2013) Two million Americans are allergic to insect stings, an allergy which sends more than 500,000 people to the emergency room annually. Yet, according to a study published today in the March issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAA), while fire ant allergy sufferers know allergy shots can save their life, more than 60 percent do not adhere to treatment guidelines.

For optimal protection against fire ant stings, allergists recommend allergy shots, also known as immunotherapy, be administered monthly. With this course of treatment, it has been proven allergy shots can modify and prevent disease progression. It can also lessen the chance for anaphylaxis, a severe allergic reaction that can be deadly.

"Our research found only 35 percent of fire ant allergic respondents adhered to treatment guidelines after one year," said allergist Shayne Stokes, MD, ACAAI member and lead study author. "Inconvenience and fear were reported as reasons why the recommendations were not followed."

Immunotherapy is currently the only disease-modifying treatment available for fire ant stings, and other allergies, within the United States.

"Immunotherapy is proven to be safe and efficient at treating allergic diseases," said Dr. Stokes. "It can also result in health care savings of 33 to 41 percent. Allergists are specialists in administering these injections which can cure patients of symptoms and prevent the development of other allergies and severe allergic reactions."

According to the ACAAI, fire ants are common throughout the southeastern United States. People who have had an allergic reaction to a sting in the past have a 60 percent chance of receiving a similar or more severe reaction if stung again. Sting attack rates have been reported as high as 50 percent, even for individuals only briefly visit
'/>"/>

Contact: Christine Westendorf
ChristineWestendorf@acaai.org
847-427-1200
American College of Allergy, Asthma, and Immunology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Californias Tobacco Control Program generates huge health care savings, UCSF study shows
2. Clixon Web-based Dental Purchasing and Inventory Management Identifies Inventory Cost Savings for the Dental Industry in 2013
3. Tomorrows life-saving medications may currently be living at the bottom of the sea
4. Inaccurate diagnoses of melanoma by smartphone apps could delay doctor visits, life-saving treatment
5. Eco Smart Energy, LLC Successfully Installs Eco-Friendly, Cost Saving Sun Equinox System at Dallas Stars’ Dr. Pepper StarCenter
6. United Way of Haywood County Launches Coast2Coast Rx Partnership to Give Consumers Prescription Savings
7. ABC Rx Cards Announced it Generated Over $237,000 of Savings for Clients
8. After Christmas Sales - Boosting Bigger Savings
9. Diet Guide Published on Dec. 3 by Clear Passage Physical Therapy Provides Life-Saving Information
10. Saving Carbs for Dinnertime Might Help Control Weight
11. QuickMedical Announces QM-Elite Nitrile Gloves Available In New 200/Box Money Saving Package
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... (PRWEB) March 29, 2015 The ... for Women’s Cancer announce today that Dr. Beth ... of the Claudia Cohen Research Foundation Prize for Outstanding ... the Society of Gynecologic Oncology 46th Annual Meeting on ... of the Cedars-Sinai Women’s Cancer Program at the Samuel ...
(Date:3/29/2015)... 29, 2015 Youth Villages will participate ... Oregon to assess the feasibility of implementing a Pay ... behavioral problems and their families. , Third Sector Capital ... that will be provided technical assistance throughout 2015 toward ... six other national awardees chosen by Third Sector. The ...
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... Take a bite of warm, gooey ... Acids tumble into the stomach, ready to break down ... lets these acids run amok, triggering a burning sensation ... More than 60 million Americans have heartburn at least ... starts, and how it can be stopped. , Heartburn ...
(Date:3/28/2015)... New York, NY (PRWEB) March 28, 2015 ... clinic that offers urgent care in Manhattan, recently commemorated ... urgent care facility in Manhattan. In addition to 24-hour ... to ER facilities. , At this time, Emergency ... treatments for abdominal pain, asthma, chest pain, eye injuries, ...
Breaking Medicine News(10 mins):Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2
... Preserves Competition for Medicare Advantage,Plans Sold to Senior ... of,Justice announced today that it will require UnitedHealth ... to divest assets relating,to United,s Medicare Advantage business ... with United,s acquisition of Sierra. The Department said ...
... An article co-authored by Susan L. Mitchell, M.D., ... reports that nursing home residents with advanced dementia ... two weeks before death. This practice raises concerns ... with advanced dementia, as well as the emergence ...
... place burden on Medicare, analysis finds , , MONDAY, Feb. ... Americans newly diagnosed with heart failure has declined, the ... new research finds. , The Duke University study analyzed ... diagnosed with heart failure between 1994 and 2003. It ...
... Combined hormone therapy appears to increase the risk that ... it may decrease the effectiveness of both methods for ... Feb. 25 issue of Archives of Internal Medicine, one ... Ph.D., a lead investigator at the Los Angeles Biomedical ...
... 20 percent of patients taking aspirin to lower the ... have an antiplatelet response from aspirin, the effect thought ... at Buffalo have shown. , Millions of people ... stroke, second heart attack or second episode of peripheral ...
... a Systems Biology company focussed on high quality annotation ... its abilities in the analysis of data generated by ... et al published in the January 2008 issue of ... Open Chromatin across the Genome where they identified DNase ...
Cached Medicine News:Health News:Justice Department Requires Divestiture in UnitedHealth Group's Acquisition of Sierra Health Services 2Health News:Justice Department Requires Divestiture in UnitedHealth Group's Acquisition of Sierra Health Services 3Health News:Hebrew SeniorLife researcher finds 2Health News:Hebrew SeniorLife researcher finds 3Health News:More Elderly Americans Living With Heart Failure 2Health News:LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies 2Health News:Many stroke, heart attack patients may not benefit from aspirin 2Health News:Many stroke, heart attack patients may not benefit from aspirin 3Health News:Genomatix integrates genome-wide open chromatin from next generation sequencing 2
(Date:3/29/2015)...  Three-month paliperidone palmitate, an investigational atypical antipsychotic, ... in patients with schizophrenia, according to a new ... the Journal of the American Medical ... of the study served as the basis for ... three-month paliperidone palmitate injection to treat schizophrenia in ...
(Date:3/27/2015)... YORK , March 27, 2015 BioCorRx, ... Santa Ana, California is a healthcare ... for which is estimated at $22 billion in the U.S. ... the use of FDA-approved Naltrexone in a specially compounded form ... Australia and New Zealand ...
(Date:3/27/2015)... , March 27, 2015 Across the ... to meeting challenges in clinical development, market education, and ... regulations, the Medical Affairs function is expected to increase ... markets. According to research by benchmarking ... have a group dedicated to Medical Affairs. Among companies ...
Breaking Medicine Technology:New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S. 2Medical Affairs Capabilities Expanding in Emerging Marketplaces 2
... March 23 Portola Pharmaceuticals, Inc. today announced ... 1 trial in healthy volunteers of PRT062607, a novel, ... inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, ... in vivo models of RA, PRT062607 was ...
... Conn. , March 23 Boehringer Ingelheim Pharmaceuticals, Inc., ... approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs ... advanced PD. PD is the second most common chronic neurological disorder ... ...
Cached Medicine Technology:Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications 2Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications 3Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications 4Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease 2Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease 3Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease 4Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease 5Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease 6Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease 7Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease 8
... a synthetic and porous ... free, readily available and ... controlled specification providing a ... applications include spinal fusions, ...
... the first to manufacture a diode pumped ... to announce their newest addition, the VITRA. ... the problem that many doctors face when ... No larger than a shoe box, this ...
... ART Aerosol Resistant Tips offer a safe ... Tips are designed for applications such as ... In addition, ART Tips are excellent for ... forensic studies. ART Tips prevent aerosol contaminants ...
... conveniently in plastic-wrapped racks of 96 tips, ... need to autoclave. Sterilized Diamond Tips are ... and are delivered with a certificate of ... Diamond Tips are certified free of detectable ...
Medicine Products: